Applications of tissue microarray technology.
Tissue microarrays (TMAs) have become a standard tool for tissue-based research during the last decade. In cancer research, depending on the available data attached to the arrayed tissue, three main types of arrays are commonly manufactured. Prevalence TMAs have no further data available and are suited to estimate the frequency of the occurrence of a particular alteration. Progression arrays include tissues of different stages of disease, and are instrumental to study the role of a marker protein for tumor initiation, progression, or metastatic growth. Prognosis TMAs contain tissues with patient follow-up data. These TMAs are the key to uncover the clinical impact of molecular markers. In combination with normal tissue arrays representing healthy tissues, prevalence, progression, and prognosis TMAs allow for a rapid and comprehensive analysis of molecular markers in human cancers. TMAs are also successfully used for many noncancer applications, such as Alzheimer's or inflammatory disease research.
Simon
Ronald
R
Institute of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany. r.simon@uke.de
D000544:Alzheimer Disease / Q000473:pathology; D001706:Biopsy; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis / Q000473:pathology; D011379:Prognosis; D046888:Tissue Array Analysis / Q000379:methods*